Operating Profit Cambio Fecha
AbbVie USD 3.2B 914M 2023-12
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Acorda Therapeutics USD -3632000 7.84M 2023-06
ALKERMES USD 43.85M 195.34M 2023-09
Amgen USD 1.27B 819M 2023-12
Bayer EUR -3594000000 2.64B 2023-09
Biogen USD 358.9M 200.1M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Bristol-Myers Squibb USD 1.85B 473M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
Incyte USD 187.27M 27.44M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Marinus Pharmaceuticals USD -31646000 207K 2023-09
Merck USD -1933000000 7.68B 2023-12
Moderna USD 6M 2.02B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
PTC Therapeutics USD -131738000 13.57M 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
United Therapeutics USD 260.1M 66.9M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Biogen Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.